Default company panoramic image
Logo

Neurolutions, Inc.

IpsiHand - an innovative brain controlled rehabilitation device that will potentially restore hand function to hemiparetic stroke survivors.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD

Company Summary

Neurolutions seeks to develop a revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The Company's first product, the IpsiHand, is a non-invasive EEG BCI device that will be used in a rehabilitation protocol to restore hand function to hemiparetic stroke survivors.

Team

  • Default avatar
    Tara Butler, MD
    Interim CEO and Chairman of the Board

    Dr. Butler is Interim CEO and Chairman of the Board.As Investment Diretor of Ascension Health Ventures, Dr. Butler was a founder of Neurolutions and has been active Chairman of the Board since its inception. She has over 20 years of experience in medical technology development and is a Board Member on several of AHV's portfolio Companies.

  • Default avatar
    Melissa Walker, MS, RAC, FRAPS
    Clinical and Regulatory Strategy Consultant

    Ms. Walker is an accomplished senior executive with over 25 years of experience, including proven expertise in business management, regulatory affairs, quality systems, healthcare compliance, and clinical research.

  • Default avatar
    Dan Moran, PhD
    Co-Founder and Scientific Advisor

    Dr. Moran is Associate Professor of Biomedical Engineering at Washington University in St. Louis. Dr. Moran is an inventor of the Neurolutions platform and is a world renowned expert in BCI technology.

  • Default avatar
    Thy Nguyen Huskey, M.D., FAAPMR
    Principal Investigator

    Dr. Huskey is Associate Professor of Neurology at Washington University in St. Louis, and President of the Medical Staff at the Rehabilitation Institute of St. Louis. Dr. Huskey is an experienced clinical trial investigator who has a particular interest in rehabilitative devices for patients with hemiparesis due to stroke.

  • Default avatar
    Rob Coker
    Software Developer

    Mr. Coker is a software developer with extensive experience across a wide variety of operating systems and platforms. Mr. Coker has an M.S. in Electrical Engineering and is currently working towards his M.S. in Biomedical Engineering.

  • Default avatar
    Eric Leuthardt, MD
    Co-Founder, Board Member, and Scientific Advisor

    Dr. Leuthardt is Assistant Professor of Neurosurgery and Director of the Center for Innovation and Technology at Washington University in St. Louis. Dr. Leuthardt is an inventor of the Neurolutions platform and is a world renowned expert in BCI technology.

Advisors

  • Default avatar
    Bryan Cave
    Lawyer
    Unconfirmed
    Default avatar
    Stone Carlie
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Ascension Health Ventures - Current Investor
    Unconfirmed
    Default avatar
    BioGenerator - Current Investor
    Unconfirmed
    Default avatar
    Missouri Technology Corporation - Committed pending diligence
    Unconfirmed